Genetic polymorphisms of CXCR5 and CXCL13 are associated with non-responsiveness to the hepatitis B vaccine

Vaccine. 2014 Sep 15;32(41):5316-22. doi: 10.1016/j.vaccine.2014.07.064. Epub 2014 Jul 29.

Abstract

A cohort based study has been undertaken to investigate the possible association of genetic polymorphisms in genes functionally related to follicular T helper (TfH) cells with non-responsiveness to hepatitis B virus (HBV) vaccination. A total of 24 single nucleotide polymorphisms (SNPs) in 6 TfH related genes (CXCR5, ICOS, CXCL13, IL-21, BCL6 and CD40L) were investigated in 20 non-responders and 45 responders to HBV vaccination. Genetic association analysis revealed that three SNPs (rs497916, rs3922, rs676925) in CXCR5 and one SNP (rs355687) in CXCL13 were associated with hepatitis B vaccine efficacy. In addition, significantly unbalanced distributions of two haplotypes, defined by three SNPs (rs497916, rs3922, rs676925) within CXCR5, were also seen between non-responders and responders. Furthermore, we demonstrated that the rs3922 "GG" genotype was associated with higher levels of CXCR5 than the "AG" and "AA" genotype in a group of healthy volunteers. A dual luciferase report assay was used to confirm that the "G" allele in rs3922 may lead to higher gene expression than the "A" allele, implicating that rs3922 might be a functional SNP affecting CXCR5 expression. These results indicated that polymorphism associated changes in CXCR5 expression in TfH cells may be associated with non-responsiveness to hepatitis B vaccination.

Keywords: CXCL13; CXCR5; Follicular T helper cell; Hepatitis B vaccine; Non-response; Polymorphism.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Chemokine CXCL13 / genetics*
  • Female
  • Genotype
  • Haplotypes
  • Hepatitis B Vaccines / immunology*
  • Hepatitis B Vaccines / therapeutic use
  • Humans
  • Male
  • Middle Aged
  • Polymorphism, Single Nucleotide*
  • Receptors, CXCR5 / genetics*
  • T-Lymphocytes, Helper-Inducer / immunology
  • Treatment Failure

Substances

  • CXCL13 protein, human
  • CXCR5 protein, human
  • Chemokine CXCL13
  • Hepatitis B Vaccines
  • Receptors, CXCR5